Back to search

National and Kapodistrian University of Athens

Συγκριτική μελέτη καρκινικών δεικτών μεταξύ συστηματικής και πυλαίας κυκλοφορίας σε ασθενείς με καρκίνο παχέος εντέρου: προγνωστική σημασία

Abstract

dc:description

Αim: The KiSS-1 gene is located in chromosome 1. Coupled with its receptor AXOR12 (GPR54 or hOT7T175) has found to have a powerful antimetastatic action in malignant tumors of many species. The purpose of this paper is to study the clinical significance of the concentration levels of KiSS-1 gene in systemic and portal circulation, and of the tissue expression of KiSS-1 and AXOR12 genes in patients with colon cancer. Material - Method: First were studied sixteen patients with colorectal cancer, of which eight with liver metastases and then fifty three patients with colon cancer of all stages (by Dukes and Astler-Coller). Also twentyone cases of liver metastases were studied. The expression of KiSS-1 and AXOR12 proteins was studied by immunohistochemical method using the appropriate antibodies. In the statistical analysis which followed, the expression levels of KiSS-1 and AXOR12 correlated with the clinicopathological characters of the disease and the survival of the patients. Results: Regarding the concentration of KiSS-1 gene in systemic and portal circulation (blood expression), no statistically significant relationship was found with the tumor stage and patient survival. Regarding the tissue expression of KiSS-1 and AXOR12, high expression of KiSS-1 was found in 67.9% and of AXOR12 in 58.5% for cases of primary tumor while for cases with metastases in 64.9% and 43.2% respectively. High expression of AXOR12 statistically significant was observed in Dukes and Astler-Coller stage D, in the primary tumor as compared with metastases and in stages T3 and T4, while high expression of KiSS-1 in cases of positive lymph node metastasis, well differentiation of the tumor and stage B1 compared to B2 in Astler-Coller. Survival was significantly longer for cases with high expression of AXOR12 (average survival up to 49.6 months, p=0,004) than that of KiSS-1 (20.9 months) with three years survival probability up to 77.8%. Patients with high expression of AXOR12 had up to 68% lower risk of death compared with patients with low expression. Conclusions: In patients with colon cancer and those with liver metastases from colon cancer, high expression of AXOR12 is associated with increased survival and could be regarded as an independent prognostic factor of survival. Survival did not differ significantly depending on the expression of KiSS-1 and is independent of its concentration levels at the systemic and portal circulation.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Mathaiou, Spyridon
  • Ματθαίου, Σπυρίδων

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24322

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Mathaiou, Spyridon; Ματθαίου, Σπυρίδων. Συγκριτική μελέτη καρκινικών δεικτών μεταξύ συστηματικής και πυλαίας κυκλοφορίας σε ασθενείς με καρκίνο παχέος εντέρου: προγνωστική σημασία. National and Kapodistrian University of Athens, 2010. http://hdl.handle.net/10442/hedi/24322